How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences.

Context: In 2015, the Centers for Medicare and Medicaid Services (CMS) urged state Medicaid programs to use 1115 waiver demonstrations to expand substance use treatment benefits. We analyzed four critical points in states' decision-making processes before expanding benefits. Methods: We conducted qu...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Health Politics, Policy & Law Vol. 47; no. 4; pp. 497 - 519
Autores principales: Crable, Erika, Jones, David K., Walley, Alexander Y., Hicks, Jacqueline Milton, Benintendi, Allyn, Drainoni, Mari-Lynn
Formato: Artículo
Publicado: Duke University Press Aug2022
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=158245788&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 158245788
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        03616878
        HPP
      jtl: Journal of Health Politics, Policy & Law
      issn: 03616878
      maglogo: N
    pubinfo:
      dt: Aug2022
      vid: 47
      iid: 4
      pid: 154
      pub: Duke University Press
    artinfo:
      ui:
        158245788
        10.1215/03616878-9716740
      ppf: 497
      ppct: 22
      formats:
      tig:
        atl: How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences.
      aug:
        au:
          Crable, Erika
          Jones, David K.
          Walley, Alexander Y.
          Hicks, Jacqueline Milton
          Benintendi, Allyn
          Drainoni, Mari-Lynn
        affil:
          University of California San Diego
          Boston University
      su:
        United States
        Centers for Medicare & Medicaid Services (U.S.)
        Substance abuse treatment
        Medical quality control
        Interviewing
        Qualitative research
        Policy sciences
        Research methodology
        Comparative studies
        Descriptive statistics
        Research funding
        Thematic analysis
      sug:
        subj:
          Substance abuse treatment
          Medical quality control
          Interviewing
          Qualitative research
          Policy sciences
          United States
          Centers for Medicare & Medicaid Services (U.S.)
          Psychiatric and Substance Abuse Hospitals
          Outpatient Mental Health and Substance Abuse Centers
          Administration of Human Resource Programs (except Education, Public Health, and Veterans' Affairs Programs)
          Research methodology
          Comparative studies
          Descriptive statistics
          Research funding
          Thematic analysis
      keyword:
        1115 waivers
        implementation science
        Medicaid
        substance use
        1115 waivers
        implementation science
        Medicaid
        substance use
      ab: Context: In 2015, the Centers for Medicare and Medicaid Services (CMS) urged state Medicaid programs to use 1115 waiver demonstrations to expand substance use treatment benefits. We analyzed four critical points in states' decision-making processes before expanding benefits. Methods: We conducted qualitative cross-case comparison of three states that were early adopters of the 1115 waiver request. We conducted 44 interviews with key informants from CMS, Medicaid, and other state agencies, providers, and managed care organizations. Findings: Policy makers expanded substance use treatment in response to "fragmented" care systems and unsustainable funding streams. Medicaid staff had mixed preferences for implementing new benefits via 1115 waivers or state plan amendments. The 1115 waiver process enabled states to provide coverage for residential benefits, but state plan amendments made other services permanent parts of the benefit. Medicaid agencies relied on interorganizational networks to identify evidence-based practices. Medicaid staff secured legislative support for reform by focusing on program integrity concerns and downstream effects of substance use rather than Medicaid beneficiaries' needs. Conclusions: Decision-making processes were influenced by Medicaid agency characteristics and interorganizational partnerships, not federal executive branch influence. Lessons from early-adopter states provide a road map for other state Medicaid agencies considering similar reform.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N